Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | The effect of aerobic exercise on immune biomarkers and symptoms severity and progression in patients with COVID-19 : a randomized control trial (2021) |
Auteurs : | Ayman A. Mohamed ; Ayman A. Mohamed ; Motaz Alawna |
Type de document : | Article |
Dans : | Journal of Bodywork and Movement Therapies (Vol. 28, October 2021) |
Article en page(s) : | p. 425-432 |
Note générale : | https://doi.org/10.1016/j.jbmt.2021.07.012 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Adulte ; COVID-19 ; Essai contrôlé randomisé ; Exercice physique ; Humains ; Immunologie ; Jeune adulte (19-24 ans) ; Marqueurs biologiques ; Qualité de vie ; SARS-CoV-2 |
Mots-clés: | Aerobic exercise ; Aerobic capacity ; Immune biomarkers ; Immune system |
Résumé : | Background The World Health Organization in March 2020 has announced that COVID-19 is a world pandemic because the number of infected cases increases rapidly. however, there are several available vaccines, their protection is limited to a certain period. Thus, the role of modalities that improve immune functions should be performed to counter COVID-19 viral load and decrease mortality rates. Objective To investigate the effect of aerobic exercise on immune biomarkers, disease severity, and progression in patients with COVID-19. Design A randomized controlled study. Participants Thirty patients with COVID-19 participated in this study. Participants? age ranged from 24 to 45 years old. Participants had a mild or moderate COVID-19. Participants were assigned randomly into two groups, exercise and control groups. There were two main dependent variables including blood immune markers and severity of respiratory symptoms. Interventions All participants performed 2 weeks of moderate-intensity aerobic exercise for 40 min/session, 3 sessions/week. The measurements were performed at baseline, and after 2-weeks. Results At baseline measurements, there were non-significant differences between both groups in the Wisconsin scale total score, Leucocytes, Lymphocytes, Interleukin-6, Interleukin-10, Immunoglobulin-A, and TNF-? (P > .05). After the intervention, the Wisconsin scale (patient-oriented illness-specific quality-of-life) total score significantly decreased in the intervention group (P |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S1360859221001674 |